New Journey Health Technology Group Co.,LTD (SHE:002219)
China · Delayed Price · Currency is CNY 2.090
+0.010 (0.48%)
Aug 3, 2026, 3:04 PM CST
SHE:002219 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 25.76 | 30.94 | 114.77 | 28.97 | 156.12 | -371.43 |
Depreciation & Amortization | 187.18 | 187.18 | 215.95 | 238.04 | 166.52 | 163.29 |
Other Amortization | 39.38 | 39.38 | 28.76 | 29.66 | 18.76 | 14.75 |
Loss (Gain) From Sale of Assets | -0.23 | -0.23 | 0.07 | 0.19 | -0 | 0.7 |
Asset Writedown & Restructuring Costs | 1.25 | 1.25 | 1.01 | 3 | 29.46 | 119.71 |
Loss (Gain) From Sale of Investments | 3.41 | 3.41 | -2.57 | -11.85 | -47.84 | -25.69 |
Provision & Write-off of Bad Debts | 60.94 | 60.94 | 31.75 | 72.65 | - | 105.03 |
Other Operating Activities | 161.51 | 131.2 | 169.12 | 181.26 | 151.35 | 299.76 |
Change in Accounts Receivable | -22.58 | -22.58 | -117.35 | -162.1 | -160.17 | -70.23 |
Change in Inventory | 51.09 | 51.09 | 25.21 | -47.01 | 19.52 | -7.27 |
Change in Accounts Payable | -168.66 | -168.66 | -43.01 | 22.19 | -46.28 | 71.76 |
Operating Cash Flow | 318.91 | 293.79 | 438.51 | 320.93 | 268.04 | 277.29 |
Operating Cash Flow Growth | -16.32% | -33.00% | 36.64% | 19.73% | -3.34% | -2.29% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Capital Expenditures | -198.18 | -257 | -307.44 | -209.68 | -221.58 | -198.73 |
Sale of Property, Plant & Equipment | 0.22 | 0.21 | 1.84 | 0.39 | 0.28 | 1.35 |
Cash Acquisitions | -26.97 | -161.93 | -172.92 | -139.54 | -18 | -1 |
Divestitures | - | 0 | 2.15 | 0.7 | 67 | - |
Investment in Securities | - | - | -13.95 | -5.18 | 1 | -1 |
Other Investing Activities | - | - | - | 0.26 | -21.01 | 0.29 |
Investing Cash Flow | -224.93 | -418.73 | -490.31 | -353.05 | -192.31 | -199.09 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Short-Term Debt Issued | - | 53.65 | 5.64 | 16.52 | 66.65 | 54.42 |
Long-Term Debt Issued | - | 1,447 | 1,608 | 1,358 | 374.63 | 374.86 |
Total Debt Issued | 1,412 | 1,501 | 1,614 | 1,374 | 441.28 | 429.28 |
Short-Term Debt Repaid | - | -119.49 | -48.44 | -91.25 | - | -15.37 |
Long-Term Debt Repaid | - | -1,345 | -1,603 | -1,309 | -1,695 | -383.95 |
Total Debt Repaid | -1,626 | -1,465 | -1,652 | -1,400 | -1,695 | -399.33 |
Net Debt Issued (Repaid) | -213.34 | 35.91 | -38.35 | -25.78 | -1,254 | 29.95 |
Issuance of Common Stock | 90.36 | 112.7 | 112.7 | 284.39 | 0.59 | 1,794 |
Repurchase of Common Stock | - | - | -55.32 | -19.51 | - | - |
Common Dividends Paid | -94.68 | -100.71 | -118.24 | -106.17 | -275.82 | -54.18 |
Other Financing Activities | -31.35 | -3 | -10.53 | -86.53 | - | -0.08 |
Financing Cash Flow | -249.01 | 44.9 | -109.73 | 46.4 | -1,529 | 1,770 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Foreign Exchange Rate Adjustments | -0 | -0 | 0 | 0 | 0 | -0 |
Net Cash Flow | -155.03 | -80.04 | -161.53 | 14.28 | -1,453 | 1,848 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 120.73 | 36.78 | 131.06 | 111.25 | 46.47 | 78.56 |
Free Cash Flow Growth | 215.86% | -71.94% | 17.81% | 139.42% | -40.86% | 16.87% |
Free Cash Flow Margin | 4.06% | 1.21% | 3.45% | 2.84% | 1.47% | 2.60% |
Free Cash Flow Per Share | 0.04 | 0.01 | 0.04 | 0.03 | 0.01 | 0.04 |
Levered Free Cash Flow | 135.3 | -73.42 | 167.81 | -499.96 | -716.26 | 239.26 |
Unlevered Free Cash Flow | 212.25 | 3.72 | 252.2 | -419.66 | -627.12 | 383.03 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash Income Tax Paid | 100.25 | 95.7 | 107.19 | 120.24 | 0.1 | 118.06 |
Change in Working Capital | -160.28 | -160.28 | -120.35 | -221 | -206.33 | -28.82 |